Bibliografias
Schmid F. Cell Therapy: A New Dimension of Medicine. Medicina Biológica, 1983, p.455.
Yoshida K. Placenta Power: For Health and Beauty. A useful guide for those seeking placenta - based remedies.
Schmid F. Organoterapia: un paso hacia el futuro de la nueva medicina. Biotecnoquimica, 1994, p.253.
Schmid F und Stein J.: Acceptance and Distribution-Patterns of Injected Foreign Tissues. Cell Research and Cellular Therapy. Ott Publishers Thoune, Switzerland, 1967, p.143 – 152.
Kiss B, Karpati E. Mechanism of action of vinpocetine [in Hungarian; English abstract]. Acta Pharm Hung. 1996; 66:213 – 214.
Miyazaki M. The effect of a cerebral vasodilator, vinpocetine, on cerebral vascular resistance evaluated by the Doppler ultrasonic technique in patients with cerebrovascular diseases. Angiology. 1995; 46:53 – 58.
Bereczki D, Fekete I. A systematic review of vinpocetine therapy in acute ischaemic stroke. Eur J Clin Pharmacol. 1999; 55:349 – 352.
Hindmarch I, Fuchs HH, Erzigkeit H. Efficacy and tolerance of vinpocetine in ambulant patients suffering from mild to moderate organic psychosyndromes. Int Clin Psychopharmacol. 1991; 6:31 - 43.
Dragunow M, Faull RL. Neuroprotective effects of adenosine. Trends Pharmacol Sci. 1988; 9: 193 – 194.
Yan J, Fujii K, Yao J, Kishida H, Hosoe K, Sawashita J, Takeda T, Mori M, Higuchi K. Reduced coenzyme Q10 supplementation decelerates senescence in SAMP1 mice. Exp Gerontol. 2006 Feb; 41(2):130-40.
Kaneka Corporation Study. Treadmill test with the age rat at the age of 61-63 weeks. 2006.
Regul Toxicol Pharmacol. 2006 Aug 17; Absorption Comparison Using Different Form of CoQ10.Klinkhammer P. Szelies B, Heiss W. Effect of phosphatidylserine on cerebral glucose metabolism in Alzheimer’s disease. Dementia. 1990; 1:197 – 201.
Kim HY, Bigelow J, Kevala JH. Substrate preference in phosphatidylserine biosynthesis for docosahexaenoic acid containing species, Biochemistry. 2004 Feb 3; 43(4):1030 – 6.
Kidd PM. Neurodegeneration from mitochondrial insufficiency: nutrients, stem cells, growth factors, and prospects for brain rebuilding using integrative management. Altern Med Rev. 2005 Dec; 10(4):268 – 93.
Cenacchi T, Bertoldin T, Farina C, Fiori MG, Crepaldi G. Cognitive decline in the elderly: a double-blind, placebo controlled multicenter study on efficacy of phosphatidylserine administration. Aging (Milano.), 1993 Apr; 5 (2):123 – 33.
Ronald M. Klatz and Robert Goldman, Eds., Anti – Aging Medical Therapeutics, Vol. I (Health Quest Publications, Marina del Rey, California; 1997).
Ronald M. Klatz and Robert Goldman, Eds., Anti – Aging Medical Therapeutics, Vol. II (Health Quest Publications, Marina del Rey, California; 1998).
Petrov, RV Respuesta Inmune Durante el Envejecimiento. Moscú, Ed. Mir, 1987. pp. 319 – 326.
Ruano C, López-Jaramillo P. Respuesta inmune no específica y óxido nítrico: La vía L – arginina – óxido nítrico: de su descubrimiento a sus aplicaciones clínicas. Quito, Ediciones Científicas; 1995.
Measso G, Cavarzeran F, Zappala G, Lebowitz BD, Crook TH, Pirozzolo FJ, Amaducci LA, Massari D, Grigoletto F. The mini-mental state examination: normative study of an Italian random sample. Dev. Neuropsychol. 1993; 9:77 – 85.
Hayflick L. Human cells and aging. Sci Am. 1968; 218:32 – 37.
Jarisch A, Krieg T, Hunzelmann N. Regulation of collagen expression by interleukin – 1 beta is dependent on donor age. Acta Derm Venereol. 1996; 76:287 – 90.
Endotelio Cienc. Vol. 1, N° 1-2000. Antonio Carlos Jaramillo T. Revista Panamericana de Endotelio.
Bonfanti L, Peretto P, De Marchis S, Fasolo A. Carnosine-related dipeptides in the mammalian brain. Prog Neurobiol. 1999; 59:333 – 53.
Klebanov GI, Teselkin YO, Babenkova IV. Effect of carnosine and its components on free-radical reactions. Membr Cell Biol. 1998; 12:89 – 99.
Hipkiss AR, Preston JE, Himsworth DT. Pluripotent protective effects of carnosine, a naturally occurring dipeptide. Ann NY Acad Sci. 1998; 854:37 – 53.
Boldyrev AA, Johnson P, Wei Y, et al. Carnosine and taurine protect rat cerebellar granular cells from free radical damage. Neurosci Lett. 1999; 263(2-3):169 – 72.
Burcham PC, Kerr PG, Fontaine F. The antihypertensive hydralazine is an efficient scavenger of acrolein. Redox Rep. 2000; 5(1):47-9.
Suslina ZA, Federova TN, Maksimova MIu et al. Antioxidant therapy in ischemic stroke. Zh Nevrol Psikhiatr Im S S Korsakova. 2000; 100(10):34 – 8.
Kiss B, Karpati E. Mechanism of action of vinpocetine [in Hungarian; English abstract]. Acta Pharm Hung. 1996; 66:213 – 214.